ValuationViz

IMVT fund manager activity

Immunovant, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q3 2023 to Q2 2026.

Q2 2025

ManagerActivitySharesValue% of portfolioFiled
Viking Global InvestorsSold out——0.00%Aug 14, 2025

Q1 2025

ManagerActivitySharesValue% of portfolioFiled
Viking Global InvestorsTrimmed1,114,827$19,052,3930.06%May 15, 2025

Newer quarters · Older quarters